After 1:1 matching within each subgroup, the final matched cohorts comprised 123 patients per group in the overweight subgroup, 349 per group in the obese class I subgroup, and 496 per group in the obese class IIIII subgroup
Yun Z, Guo Z, Li X, Shen Y, Nan M, Dong Q, et al
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
Liver Health Significant reductions in liver fat, showing promise for fatty liver disease prevention
These data highlight the potential for berobenatide to be the first approved monthly GLP-1 RA peptide and support our extensive Phase 3 program that includes 10 studies for chronic weight management and obesity-related comorbidities, Jim List, chief internal medicine officer at Pfizer, said in a press release
Avoid the trunk, as it can heat up quickly, especially during the summer